z-logo
Premium
Methylation‐regulated miR‐149 modulates chemoresistance by targeting Glc NA c N ‐deacetylase/ N ‐sulfotransferase‐1 in human breast cancer
Author(s) -
He DongXu,
Gu XiaoTing,
Li YouRan,
Jiang Li,
Jin Jian,
Ma Xin
Publication year - 2014
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/febs.13012
Subject(s) - cancer research , microrna , heparanase , downregulation and upregulation , breast cancer , methylation , cancer , dna methylation , chemistry , biology , medicine , gene expression , metastasis , gene , biochemistry
Dysregulation of micro RNA is strongly implicated in the chemoresistance of cancer. In this study, we found that miR‐149 was downregulated and involved in chemoresistance in adriamycin ( ADM )‐resistant human breast cancer cells ( MCF ‐7/ ADM ). Downregulation of miR‐149 was related to hypermethylation of its 5′‐ UTR ; this methylation also affected the expression of the glypican 1 gene, which is both the host and the target gene of miR‐149. Furthermore, we found that miR‐149 modulated chemoresistance through targeting the expression of Glc NA c N ‐deacetylase/ N ‐sulfotransferase‐1 ( NDST 1). With downregulated miR‐149, NDST 1 expression was increased in chemoresistant MCF ‐7/ ADM cells versus control MCF ‐7 wild‐type cells. The increased NDST 1 then activated a heparan sulfate‐related pathway involving activation of heparanase. Finally, expression of miR‐149 and NDST 1 was confirmed in clinical chemoresistant samples of breast cancers receiving anthracycline/taxane‐based chemotherapies. The high expression of NDST 1 was also an unfavorable predictor for distant relapse‐free survival in Her2 and basal breast cancers. Taken together, our findings demonstrate that miR‐149 is regulated by methylation, and is a modulator of cancer chemoresistance by targeting NDST 1 .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom